BFA
PFE icon

Bill Few Associates’s Pfizer PFE Stock Holding History

Bill Few Associates’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.19M Sell
91,121
-932
-1% -$24.4K 0.47% 56
2026
Q1 		$2.58M Buy
92,053
+6,511
+8% +$173K 0.62% 45
2025
Q4 		$2.13M Buy
85,542
+1,606
+2% +$40.5K 0.52% 50
2025
Q3 		$2.14M Sell
83,936
-320
-0.4% -$7.9K 0.55% 47
2025
Q2 		$2.04M Buy
84,256
+1,957
+2% +$45.6K 0.58% 46
2025
Q1 		$2.09M Buy
82,299
+2,783
+3% +$72.8K 0.75% 39
2024
Q4 		$2.11M Sell
79,516
-7,247
-8% -$197K 0.74% 40
2024
Q3 		$2.51M Buy
86,763
+2,931
+3% +$85.5K 0.89% 33
2024
Q2 		$2.35M Buy
83,832
+1,224
+1% +$33.7K 0.9% 34
2024
Q1 		$2.29M Buy
82,608
+2,571
+3% +$71.3K 0.93% 30
2023
Q4 		$2.3M Sell
80,037
-783
-1% -$23.7K 1.05% 27
2023
Q3 		$2.68M Buy
80,820
+368
+0.5% +$13K 1.4% 23
2023
Q2 		$2.95M Buy
80,452
+2,225
+3% +$86.6K 1.53% 23
2023
Q1 		$3.19M Buy
78,227
+1,932
+3% +$83.4K 1.77% 19
2022
Q4 		$3.91M Buy
76,295
+2,211
+3% +$106K 2.31% 12
2022
Q3 		$3.24M Buy
74,084
+203
+0.3% +$9.86K 2.19% 15
2022
Q2 		$3.87M Sell
73,881
-1,486
-2% -$75.7K 2.48% 9
2022
Q1 		$3.9M Buy
75,367
+1,079
+1% +$56K 2.12% 14
2021
Q4 		$4.39M Buy
+74,288
New +$3.68M 2.27% 13

Other funds holding PFE

Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
CWP
Curated Wealth Partners El Segundo, California $774M AUM 5.71% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
FWIA
Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return
ORIO
Old Republic International (ORI) Chicago, Illinois $2.67B AUM 26.94% 1-Year Est. Return
CNB
Czech National Bank Prague, Czech Republic $18.3B AUM 43.04% 1-Year Est. Return
KC
Kepler Cheuvreux Nyon $1.75B AUM 37.37% 1-Year Est. Return
WAM
Wilsey Asset Management San Diego, California $681M AUM 6.7% 1-Year Est. Return

Bill Few Associates's PFE Position: Q2 2026 in Review

Bill Few Associates reduced its Pfizer (PFE) stake by 1% in Q2 2026, selling an estimated $24.4K and leaving 91,121 shares worth $2.19M. The position accounts for 0.47% of the portfolio, ranked #56.

Bill Few Associates first reported a position in PFE in Q4 2021 and has held it in 19 quarters since. The position peaked at $4.39M in Q4 2021. 491 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Bill Few Associates held 91,121 shares of Pfizer worth $2.19M as of Q2 2026.
  • Bill Few Associates sold 932 Pfizer shares in Q2 2026, an estimated $24.4K.
  • Pfizer made up 0.47% of Bill Few Associates's portfolio in Q2 2026, its #56 holding.
  • Bill Few Associates first reported a position in Pfizer in Q4 2021 and has held it in 19 quarters since.
  • Bill Few Associates's Pfizer position peaked at $4.39M in Q4 2021.
  • 491 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Bill Few Associates's 13F filing for Q2 2026, filed 7 Jul 2026.